Correlation Between Neurobo Pharmaceuticals and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and SAB Biotherapeutics, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and SAB Biotherapeutics.
Diversification Opportunities for Neurobo Pharmaceuticals and SAB Biotherapeutics
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neurobo and SAB is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and SAB Biotherapeutics
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Neurobo Pharmaceuticals is 28.91 times less risky than SAB Biotherapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 2.60 in SAB Biotherapeutics on August 31, 2024 and sell it today you would earn a total of 4.23 from holding SAB Biotherapeutics or generate 162.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 84.13% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. SAB Biotherapeutics
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| SAB Biotherapeutics |
Neurobo Pharmaceuticals and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and SAB Biotherapeutics
The main advantage of trading using opposite Neurobo Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |